ALNY
ALNY
NASDAQ · Biotechnology

Alnylam Pharmaceuticals Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$155.94
-0.72 (-0.46%)
As of Nov 7, 1:06 AM ET ·
Analyst Consensus
Strong Buy
38
Analysts
Very High
Coverage
Buy 29 76%
Hold 9 24%
Sell 0 0%
Price Target
Analyst Price Target -34.4% upside
Low Target $75.08
Average Target $102.31
High Target $108.98
Current Price $155.94
Current
$155.94
Target
$102.31
$75.08 $102.31 avg $108.98
Scenario Analysis
Bear Case
$75.08
-51.9%
Low target
Base Case
$102.31
-34.4%
Avg target
Bull Case
$108.98
+-30.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$479.79
-67.5% from high
52-Week Low
$156.00
+0.0% from low
50-Day SMA
$228.57
-31.8% vs SMA
200-Day SMA
$280.39
-44.4% vs SMA
RSI (14)
13.6
Oversold
Target vs 52W High
$102.31
-78.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%